Agilent 1260 Infinity III Bio-Inert Multisampler
The 1260 Infinity III Bio-Inert Multisampler injects samples from microplate and vial at pressures up to 600 bar. It is a compact module offering a capacity of up to 6,144 samples. With its multiwash capability, you can reduce carryover to less than 9 ppm.
The metal-free sample flow path makes it the ideal injector for all biorelated applications, including analysis of mAbs, proteins in general, and oligonucleotides. For temperature-sensitive samples, a highly efficient compressor-based thermostatting system can be added. The ceramic needle, PEEK needle seat, and stainless steel-clad PEEK capillaries ensure highest injection accuracy and precision.
For Research Use Only. Not for use in diagnostic procedures.
Features
- Metal-free sample flow path at 600 bar ensures that none of your precious sample touches metal surface, offering a reliable analysis of biological samples
- Multiwash capability flushes the surfaces of the injection needle with three solvents and uses seat backflush procedures to reduce carryover to less than 9 ppm
- Integrated sample thermostat, available as option or upgrade, provides cooling and heating from 4 to 40 °C
- Sample drawers are available in three heights to accommodate any combination of sample containers for maximum flexibility
- Shallow microplate drawers take a maximum load of 16 microtiter plates and up to 6,144 samples for unmatched sample capacity
- Robotics move microtiter plates and other sample containers from sample hotel to central workspace for seamless automation during sample processing steps and injections
Physicochemical characterization of coformulated monoclonal antibodies
This application note demonstrates the use of Agilent biopharma analytical tools, including cation-exchange chromatography (CEX), size exclusion chromatography (SEC), and peptide mapping, for the analysis of coformulated monoclonal antibodies (mAbs).
Analysis of Risedronate According to USP Using the Agilent 1260 Infinity Bio-inert Quaternary LC System
This Application Note by Agilent presents the analyses of USP risedronate sodium substance and of risedronate sodium tablets according to U.S. Pharmacopeia (USP) specifications



















